Pronota secures biomarker renal Dx patent; Depression biomarkers closer to reality;

> Belgium's Pronota has nailed down a crucial patent for the use of the LG3 blood biomarker in diagnosing renal failure, despite a previous U.S. Supreme Court decision questioning the practice. Item

> The Biomarker Europe Summit 2013 is scheduled for Oct. 9-10 in Berlin, Germany and will cover the latest biomarker discovery, translation and commercialization efforts. Item

> Scientists are getting much closer to developing diagnostic tests for depression biomarkers. Story

> The Biomarker France project proved genetic tumor profiling is feasible in patients with non-small-cell lung cancer and has already helped treat patients. Story

> An Arizona State University biochemist is probing the use of glycans as a possible lung cancer biomarker. Item